- Condition: Cognitive Impairment
Interventions: Other: Dual task gait training; Other: Dual task gait training; Other: Aerobic exercise class
Sponsors: Parkwood Hospital, London, Ontario; Parkwood Hospital, London, Ontario; University of Western Ontario, Canada; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Hip Fracture
Interventions: Behavioral: Rehabilitation Model of Care; Other: Usual Care
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified March 2012 - Conditions: Dementia; Alzheimer's Disease
Intervention: Other: PC-DATA tool
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified March 2012 - Condition: Mild Cognitive Impairment
Intervention: Behavioral: Cognitive training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Nova Scotia Health Research Foundation
Not yet recruiting - verified February 2012 - Conditions: Moderate to Severe Alzheimer; Alzheimer Disease
Interventions: Drug: RPh201, botanical drug product; Drug: Placebo; Drug: RPh201, botanical extract product; Drug: Placebo
Sponsors: Regenera Pharma Ltd; Regenera Pharma Ltd; Kendle Toronto, Inc, a wholly-owned subsidiary of INC Research LLC
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Mobility Limitation
Intervention: Other: Sit-to-Stand Activity
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR); CapitalCare Continuing Care; Extendicare; Good Samaritan Society; Shepherd's Care Foundation
Recruiting - verified November 2011 - Condition: Mild Cognitive Impairment
Interventions: Other: Cognitive intervention; Other: Psychosocial intervention
Sponsors: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Laval University
Not yet recruiting - verified October 2011 - Condition: Dementia
Intervention:
Sponsors: Laval University; Laval University
Not yet recruiting - verified September 2011 - Condition: Alzheimer's Disease
Interventions: Drug: rilapladib; Drug: placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 10 mg; Drug: Lu AA21004 20 mg
Sponsors: H. Lundbeck A/S; H. Lundbeck A/S
Recruiting - verified April 2012 - Condition: Frontotemporal Dementia
Interventions: Drug: oxytocin; Drug: Saline Nasal Mist
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)
Recruiting - verified June 2011 - Conditions: Cognitive Impairment; Stroke
Intervention: Behavioral: Telerehabilitation Cognitive Strategy Training
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; IWK Health Centre; Canadian Institutes of Health Research (CIHR)
Recruiting - verified August 2011 - Conditions: Delirium; Cardiac Disease
Interventions: Drug: Propofol; Drug: Dexmedetomidine
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Hospira, Inc.
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Breast Cancer
Intervention: Behavioral: Exercise
Sponsors: University of British Columbia; University of British Columbia; Canadian Breast Cancer Foundation
Recruiting - verified February 2012 - Condition: Huntington's Disease
Intervention:
Sponsors: CHDI Foundation, Inc.; CHDI Foundation, Inc.; Monash University
Recruiting - verified February 2012 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Stroke
Intervention: Drug: Lithium Carbonate
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre
Recruiting - verified August 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Vascular Cognitive Impairment
Interventions: Behavioral: Aerobic-based exercise training; Behavioral: CON (control; usual care)
Sponsors: University of British Columbia; University of British Columbia; Canadian Stroke Network; Heart and Stroke Foundation of Canada
Recruiting - verified April 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate (HD-02); Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; University of Rochester; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Amnestic Mild Cognitive Impairment; Aging
Interventions: Behavioral: Recollection Training; Behavioral: Control
Sponsors: Baycrest; Baycrest
Recruiting - verified September 2011 - Condition: Huntington's Disease
Interventions: Drug: coenzyme Q10; Other: placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS); University of Rochester
Recruiting - verified May 2012
 |
Join Clinical Trials for Dementia in Canada |
